Abstract:OBJECTIVE:To evaluate the clinical efficacy, safety and application value of rectal ultrasound-guided targeted cryoablation of prostate (TCAP) in the treatment of T3N0M0 prostate cancer.METHODS:Transrectal ultrasound (TRUS)-guided TCAPs were performed. And prostate-specific antigen (PSA), TRUS-measured prostate volume, endorectal magnetic resonance imaging (MRI) and spectroscopic imaging (MRSI) at before, 12, 24, 36 months after TCAP were recorded and evaluated. The biochemical relapse free survival (bRFS) and clinical progression (local recurrence and distant metastasis) at 1, 2 and 3 years post-cryoablation were also recorded. The post-TCAP quality of life was also observed by the EORTC questionnaire QLQ-PR25.RESULTS:The suess rate of this technique was 100%. The follow-up period had a range of 10 to 45 months. The PSA level decreased dramatically (P < 0.01). The TRUS-measured prostate volumes significantly decreased (P < 0.01) versus those at pre-cryoablation. The bRFS at 1, 2 and 3 years post-TCAP was 92.5% (37/40), 87.1% (27/31) and 73.3% (11/15) respectively. The result of quality of life showed that the sexuality scores decreased at 6 months post-TCAP, but there was no statistical significance (P = 0.06) and recovered to baseline level at 12 months. Urinary symptoms improved significantly (P < 0.01). The clinical progression rate in this study at 3 years was 24.4% (11/45). To be specific, local recurrence rate was 54.5% (6/11) and distant metastasis rate 45.5% (5/11). Repeated cryoablation was performed for the patients with local recurrence and satisfactory results were achieved during a follow-up of 10 - 15 months. Endocrine treatment was adopted for the patients with distant metastasis and appeared to have biochemical progression free survival during a follow-up of 6 - 13 months. The therapy was safe. Most of side effects were mild and there was no occurrence of severe complications such as urethral fistulas, etc.CONCLUSION:Treating T3N0M0 prostate cancer with TCAP as a monotherapy can obtain a satisfactory outcome during a follow-up of 3 years. But its clinical application value deserves further studies.

Cryosurgery ablation combined with transurethral resection of the prostate for treatment of prostate cancer with middle leaf protruding into the bladder

Percutaneous cryoabladon of prostate cancer guided by rectal ultrasound: a retrospectively analysis of 42 cases

A comparative study of two means of simultaneous treatment for benign prostate hyperplasia and bladder stone

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

Transrectal ultrasound-guided transperineal cryosnrgical ablation for localized prostate cancer

The Feasibility and Safety of Cryoablation As an Adjuvant Therapy with Transurethral Resection of Bladder Tumor: A Pilot Study.

Transrectal ultrasonography (TRUS) guided cryoablation of prostate cancer: A clinical analysis of 30 cases

Focal Cryoablation for Unifocal Prostate Cancer: Report of 12 Cases

Ultrasound-guided Percutaneous Cryoablation of Stage C and D Prostate Cancer (report of 20 Cases)

Clinical Research for Thulium Laser Vaporization Enucleation of the Prostate Combined with Traditional Transurethral Resection of Prostate for Therapy Benign Prostate Hyperplasia Larger Than 80 Millilitres

Thulium laser resection of prostate and antiandrogen therapy in treatment of patients with advanced prostatic cancer accompanied by bladder outlet obstruction

Cryosurgery as primary treatment for localized prostate cancer

Complications of Cryosurgical Ablation and Their Prevention and Treatment for Prostate Cancer

[A Preliminary Clinical Study of Targeted Cryoablation of Prostate in the Treatment of T3N0M0 Prostate Cancer].

Cryoablation for nonmetastatic castration resistant prostate cancer: feasibility, safety, quality of life and oncological outcomes

A preliminary clinical study of argon-helium cryoablation combining with intermittent hormonal therapy for locally advanced prostate cancer

The clinical application of imaging-pathology fusion guided targeted cryoablation for localized prostate cancer

Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy

Combination of transurethral pneumatic and ultrasound cystolithotripsy and transurethral resection of prostate in benign prostatic hyperplasia with bladder stones

Minimally Invasive Treatment for Begin Prostatic Hyperplasia with Bladder Stones

Simultaneous Management of Benign Prostatic Hyperplasia with Bladder Calculi Through Resectoscope